Jason M. Dwyer

6.3k total citations · 2 hit papers
21 papers, 4.9k citations indexed

About

Jason M. Dwyer is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Biological Psychiatry. According to data from OpenAlex, Jason M. Dwyer has authored 21 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 11 papers in Pharmacology and 9 papers in Biological Psychiatry. Recurrent topics in Jason M. Dwyer's work include Neuroscience and Neuropharmacology Research (13 papers), Treatment of Major Depression (10 papers) and Tryptophan and brain disorders (9 papers). Jason M. Dwyer is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Treatment of Major Depression (10 papers) and Tryptophan and brain disorders (9 papers). Jason M. Dwyer collaborates with scholars based in United States, Canada and Japan. Jason M. Dwyer's co-authors include Ronald S. Duman, Mounira Banasr, George K. Aghajanian, Boyoung Lee, Xiaoyuan Li, Nanxin Li, Masaaki Iwata, Rongjian Liu, Ashley E. Lepack and Rong-Jian Liu and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and American Journal of Psychiatry.

In The Last Decade

Jason M. Dwyer

21 papers receiving 4.8k citations

Hit Papers

mTOR-Dependent Synapse Formation Underlies the Rapid Anti... 2010 2026 2015 2020 2010 2011 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason M. Dwyer United States 19 2.6k 2.5k 2.5k 964 820 21 4.9k
Xiaoyuan Li China 18 2.5k 1.0× 2.5k 1.0× 2.7k 1.1× 1.1k 1.1× 720 0.9× 43 5.1k
Boyoung Lee South Korea 24 2.5k 0.9× 2.0k 0.8× 2.0k 0.8× 784 0.8× 995 1.2× 55 4.9k
Rong-Jian Liu United States 20 2.0k 0.8× 1.9k 0.7× 1.9k 0.8× 839 0.9× 574 0.7× 23 4.0k
Peixiong Yuan United States 38 2.0k 0.8× 1.6k 0.6× 2.0k 0.8× 864 0.9× 1.7k 2.0× 62 5.6k
Shigeyuki Chaki Japan 52 3.9k 1.5× 2.2k 0.9× 2.3k 0.9× 1.1k 1.1× 2.5k 3.0× 185 7.5k
Polymnia Georgiou United States 24 1.5k 0.6× 1.7k 0.7× 1.4k 0.6× 502 0.5× 505 0.6× 45 3.4k
Yukihiko Shirayama Japan 40 3.0k 1.2× 1.3k 0.5× 2.3k 0.9× 1.6k 1.7× 1.7k 2.0× 122 6.5k
Angela Cappiello United States 12 1.7k 0.7× 2.3k 0.9× 1.9k 0.8× 497 0.5× 443 0.5× 14 3.8k
Paul J. Carlson United States 17 1.4k 0.5× 2.2k 0.9× 1.9k 0.8× 527 0.5× 356 0.4× 24 3.7k
José Javier Miguel-Hidalgo United States 33 2.4k 0.9× 707 0.3× 1.9k 0.8× 1.2k 1.2× 1.1k 1.4× 91 5.4k

Countries citing papers authored by Jason M. Dwyer

Since Specialization
Citations

This map shows the geographic impact of Jason M. Dwyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason M. Dwyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason M. Dwyer more than expected).

Fields of papers citing papers by Jason M. Dwyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason M. Dwyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason M. Dwyer. The network helps show where Jason M. Dwyer may publish in the future.

Co-authorship network of co-authors of Jason M. Dwyer

This figure shows the co-authorship network connecting the top 25 collaborators of Jason M. Dwyer. A scholar is included among the top collaborators of Jason M. Dwyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason M. Dwyer. Jason M. Dwyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lepack, Ashley E., Eunyoung Bang, Boyoung Lee, Jason M. Dwyer, & Ronald S. Duman. (2016). Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures. Neuropharmacology. 111. 242–252. 147 indexed citations
2.
Navarria, Andrea, Eric S. Wohleb, Bhavya Voleti, et al.. (2015). Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors. Neurobiology of Disease. 82. 254–261. 100 indexed citations
3.
Dwyer, Jason M., Jaime G. Maldonado‐Avilés, Ashley E. Lepack, Ralph Dileone, & Ronald S. Duman. (2015). Ribosomal protein S6 kinase 1 signaling in prefrontal cortex controls depressive behavior. Proceedings of the National Academy of Sciences. 112(19). 6188–6193. 60 indexed citations
4.
Liu, Rong-Jian, Manabu Fuchikami, Jason M. Dwyer, et al.. (2013). GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine. Neuropsychopharmacology. 38(11). 2268–2277. 209 indexed citations
5.
Dwyer, Jason M. & Ronald S. Duman. (2013). Activation of Mammalian Target of Rapamycin and Synaptogenesis: Role in the Actions of Rapid-Acting Antidepressants. Biological Psychiatry. 73(12). 1189–1198. 105 indexed citations
6.
Dwyer, Jason M., Ashley E. Lepack, & Ronald S. Duman. (2013). mGluR2/3 blockade produces rapid and long-lasting reversal of anhedonia caused by chronic stress exposure. PubMed. 1(1). 15–15. 65 indexed citations
7.
Banasr, Mounira, Jason M. Dwyer, & Ronald S. Duman. (2011). Cell atrophy and loss in depression: reversal by antidepressant treatment. Current Opinion in Cell Biology. 23(6). 730–737. 168 indexed citations
8.
Li, Nanxin, Rong-Jian Liu, Jason M. Dwyer, et al.. (2011). Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure. Biological Psychiatry. 69(8). 754–761. 893 indexed citations breakdown →
9.
Dwyer, Jason M., Ashley E. Lepack, & Ronald S. Duman. (2011). mTOR activation is required for the antidepressant effects of mGluR2/3 blockade. The International Journal of Neuropsychopharmacology. 15(4). 429–434. 144 indexed citations
10.
Li, Nanxin, Boyoung Lee, Rongjian Liu, et al.. (2010). mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists. Science. 329(5994). 959–964. 2240 indexed citations breakdown →
11.
Gilbert, A., Matthew G. Bursavich, Sabrina Lombardi, et al.. (2010). 3-(Pyridin-2-yl-ethynyl)benzamide metabotropic glutamate receptor 5 negative allosteric modulators: Hit to lead studies. Bioorganic & Medicinal Chemistry Letters. 21(1). 195–199. 3 indexed citations
12.
Beyer, Chad E., Jason M. Dwyer, Brian J. Platt, et al.. (2010). Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation. Psychopharmacology. 209(4). 303–311. 23 indexed citations
13.
Beyer, Chad E., Jason M. Dwyer, Michael J. Piesla, et al.. (2010). Depression-like phenotype following chronic CB1 receptor antagonism. Neurobiology of Disease. 39(2). 148–155. 124 indexed citations
14.
Kelly, Michy P., Sheree F. Logue, Jason M. Dwyer, et al.. (2009). The supra-additive hyperactivity caused by an amphetamine–chlordiazepoxide mixture exhibits an inverted-U dose response: Negative implications for the use of a model in screening for mood stabilizers. Pharmacology Biochemistry and Behavior. 92(4). 649–654. 18 indexed citations
15.
Ring, Robert H., Lee E. Schechter, Sarah K. Leonard, et al.. (2009). Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist. Neuropharmacology. 58(1). 69–77. 124 indexed citations
16.
Dwyer, Jason M., Stacey J. Sukoff Rizzo, Sarah J. Neal Webb, et al.. (2008). Acid sensing ion channel (ASIC) inhibitors exhibit anxiolytic-like activity in preclinical pharmacological models. Psychopharmacology. 203(1). 41–52. 38 indexed citations
17.
Leonard, Sarah K., Jason M. Dwyer, Stacey J. Sukoff Rizzo, et al.. (2008). Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology. 197(4). 601–611. 123 indexed citations
18.
Hughes, Zoë A., Feng Liu, Brian J. Platt, et al.. (2008). WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent. Neuropharmacology. 54(7). 1136–1142. 63 indexed citations
19.
Arias, Robert L., Mei-Li Amy Sung, Dmytro V. Vasylyev, et al.. (2008). Amiloride is neuroprotective in an MPTP model of Parkinson's disease. Neurobiology of Disease. 31(3). 334–341. 104 indexed citations
20.
Balu, Darrick T., Georgia E. Hodes, Zia Ur Rahman, et al.. (2008). Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse. Journal of Pharmacological and Toxicological Methods. 59(2). 100–107. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026